Beijing Strong Biotechnologies, Inc. (300406.SZ)
CNY 14.39
(0.7%)
CNY 14.39
(0.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 585.09 Million | 396.16 Million | 341.09 Million | 123.05 Million | 188.6 Million | 256.14 Million |
| Net Income | 522.06 Million | 394.49 Million | 469.65 Million | 121.67 Million | 331.64 Million | 300.66 Million |
| Depreciation & Amortization | 56.2 Million | 54.81 Million | 43.62 Million | 30.21 Million | 20.54 Million | 16.25 Million |
| Deferred income taxes | -9.49 Million | -7.56 Million | -12.65 Million | 7.17 Million | -6.7 Million | -709.87 Thousand |
| Stock-based compensation | 13.22 Million | 6.76 Million | 34.89 Million | 640.3 Thousand | 2.41 Million | 4.9 Million |
| Change in working capital | -54.36 Million | -136.95 Million | -219.37 Million | -75.49 Million | -178.86 Million | -68.87 Million |
| Other non-cash items | 61.18 Million | 83.81 Million | 47.19 Million | 46.66 Million | 15.26 Million | 8.1 Million |
| Investing Cash Flow | -127.21 Million | -440.82 Million | -1.31 Billion | -1.07 Billion | -387.37 Million | -243.09 Million |
| Investments in PPE | -148.03 Million | -96.47 Million | -65.2 Million | -17.24 Million | -61.41 Million | -73.09 Million |
| Acquisitions | 1.03 Million | -1.44 Million | 225.1 Thousand | -1.09 Billion | 61.41 Million | - |
| Investment purchases | -336 Million | -479.27 Million | -1.58 Billion | -55 Million | -500 Million | -170 Million |
| Sales/Maturities of investments | 356.05 Million | 148.78 Million | 333.89 Million | 88.11 Million | 174.04 Million | - |
| Other Investing Activities | -268.46 Thousand | -12.4 Million | 0.35 | 340.92 Thousand | -61.41 Million | -73.09 Million |
| Financing Cash Flow | -74.75 Million | -10.58 Million | 776.67 Million | 1.3 Billion | -55.75 Million | -215.92 Million |
| Debt repayment | -101.8 Million | -1.15 Billion | -301.14 Million | -243.28 Million | -84 Million | - |
| Dividends payments | -58.59 Million | -58.81 Million | -58.41 Million | -74.54 Million | -74.54 Million | -75.27 Million |
| Common Stock Repurchased | -49.45 Million | -51.1 Million | - | - | - | -75.56 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -11.79 Million | 1.23 Billion | 1.15 Billion | 1.63 Billion | 102.9 Million | -140.65 Million |
| Accounts receivables | -69.02 Million | -84.94 Million | -184.22 Million | -34 Million | -135.33 Million | -69.63 Million |
| Accounts payables | 37.36 Million | -33.2 Million | 8.5 Million | 16.37 Million | -848.28 Thousand | -2.9 Million |
| Inventory | -13.21 Million | -11.24 Million | -31 Million | -65.03 Million | -35.96 Million | 4.37 Million |
| Other working capital | -9.49 Million | -7.56 Million | -12.65 Million | 7.17 Million | -6.7 Million | -73.25 Million |
| Cash at beginning of period | 328.31 Million | 382.51 Million | 577.18 Million | 225.66 Million | 480.11 Million | 683.09 Million |
| Cash at end of period | 711.63 Million | 328.31 Million | 382.51 Million | 577.18 Million | 225.66 Million | 480.11 Million |
| Capital Expenditure | -148.03 Million | -96.47 Million | -65.2 Million | -17.24 Million | -61.41 Million | -73.09 Million |
| Effect of forex changes on cash | 196.19 Thousand | 1.03 Million | -364.54 Thousand | -382.41 Thousand | 71.85 Thousand | -94.34 Thousand |
| Net cash flow / Change in cash | 383.31 Million | -54.2 Million | -194.66 Million | 351.51 Million | -254.44 Million | -202.97 Million |
| Free Cash Flow | 437.06 Million | 299.68 Million | 275.89 Million | 105.81 Million | 127.19 Million | 183.04 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 123.01 Million | 129.72 Million | 120.64 Million | 522.06 Million | 152.42 Million | 129.74 Million |
| Depreciation & Amortization | - | 17.68 Million | 17.68 Million | 56.2 Million | 14.8 Million | 14.8 Million |
| Deferred income taxes | - | - | - | -9.49 Million | 69.01 Million | -100.81 Million |
| Stock-based compensation | - | 16.87 Million | - | 13.22 Million | 13.22 Million | -3.22 Million |
| Change in working capital | - | -19.52 Million | - | -54.36 Million | -82.23 Million | 104.03 Million |
| Other non-cash items | 61.01 Million | 101.49 Million | -93.64 Million | 61.18 Million | 50.92 Million | 55.61 Million |
| Investing Cash Flow | -203.69 Million | -42.28 Million | 275.34 Million | -127.21 Million | 120.18 Million | -92.41 Million |
| Investments in PPE | -10.96 Million | -8.85 Million | -39.38 Million | -148.03 Million | -38.71 Million | -32.17 Million |
| Acquisitions | 120.6 Thousand | 168.8 Thousand | 162.4 Thousand | 1.03 Million | -0.32 | 60.24 Million |
| Investment purchases | -142 Million | -34.88 Million | - | -336 Million | -191 Million | -51 Million |
| Sales/Maturities of investments | -50.85 Million | -11.11 Million | 314.56 Million | 356.05 Million | 349.91 Million | -9.24 Million |
| Other Investing Activities | 120.6 Thousand | 12.4 Million | 314.73 Million | -268.46 Thousand | -19.8 Thousand | -60.24 Million |
| Financing Cash Flow | -23.88 Million | -151.78 Million | 17.13 Million | -74.75 Million | -17.26 Million | -10.4 Million |
| Debt repayment | -201.8 Thousand | -15.49 Million | -22.02 Million | -101.8 Million | -30.02 Million | -50.21 Million |
| Dividends payments | -117.42 Million | -123.65 Million | - | -58.59 Million | -58.59 Million | -1.21 Million |
| Common Stock Repurchased | 14.29 Million | -14.29 Million | - | -49.45 Million | -49.45 Million | 10.85 Million |
| Common Stock Issuance | - | - | - | - | - | -10.85 Million |
| Other Financing Activities | -23.45 Million | -121.84 Million | -1.81 Million | -11.79 Million | -12.49 Million | 41.02 Million |
| Accounts receivables | - | -24.14 Million | - | -69.02 Million | -69.02 Million | 104.26 Million |
| Accounts payables | - | - | - | 37.36 Million | - | - |
| Inventory | - | 4.62 Million | - | -13.21 Million | -13.21 Million | -231.46 Thousand |
| Other working capital | - | - | - | -9.49 Million | - | - |
| Cash at beginning of period | 1.04 Billion | 1.03 Billion | 711.63 Million | 328.31 Million | 390.5 Million | 294.07 Million |
| Cash at end of period | 994.55 Million | 1.04 Billion | 1.02 Billion | 711.63 Million | 711.63 Million | 390.5 Million |
| Capital Expenditure | -10.96 Million | -8.85 Million | -39.38 Million | -148.03 Million | -38.71 Million | -32.17 Million |
| Effect of forex changes on cash | 168.74 Thousand | 312.9 Thousand | -284.32 Thousand | 196.19 Thousand | 49.92 Thousand | -149.93 Thousand |
| Net cash flow / Change in cash | -46.6 Million | 7.37 Million | 309.74 Million | 383.31 Million | 321.12 Million | 96.43 Million |
| Free Cash Flow | 173.06 Million | 204.67 Million | -12.38 Million | 437.06 Million | 179.44 Million | 167.99 Million |
APLUF
RHE
2942
5212
ALWEC
688090